| OSMAX | OSMNX | OSMAX / OSMNX | |
| Total Expense Ratio | 1.37 | 1.63 | 84% |
| Annual Report Gross Expense Ratio | 1.37 | 1.63 | 84% |
| Fund Existence | 28 years | 25 years | - |
| Gain YTD | 2.817 | 2.780 | 101% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.56B | 2.56B | 100% |
| Annual Yield % from dividends | 1.40 | 1.26 | 111% |
| Returns for 1 year | -2.47 | -4.35 | 57% |
| Returns for 3 years | -12.49 | -15.32 | 82% |
| Returns for 5 years | -31.87 | -34.89 | 91% |
| Returns for 10 years | 12.55 | 4.80 | 261% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIOCX | 11.64 | 0.16 | +1.39% |
| American Century International Opps C | |||
| FVILX | 6.30 | 0.07 | +1.12% |
| Forester Value I | |||
| GIRVX | 8.98 | 0.01 | +0.11% |
| Goldman Sachs Intl Eq Div & Prem Inv | |||
| GIEYX | 16.54 | N/A | N/A |
| GuideStone Funds International Eq Instl | |||
| JFNSX | 77.29 | -0.49 | -0.63% |
| Janus Henderson Global Life Sciences S | |||